# Therapeutic Catalyst

**Funder:** Cancer Research UK
**Budget:** Up to £250k
**Deadline:** 25 September 2026 (Expression of interest deadline; scheme was paused and expected to relaunch early July 2026. Next EOI deadline after relaunch: 25 September 2026.)
**Duration:** Up to 18 months
**Consortium:** No
**Application:** 2-stage: expression of interest → full proposal
**Frequency:** Annual
**Eligible countries:** GB
**Official call:** https://www.cancerresearchuk.org/for-researchers/apply-for-and-manage-your-funding/our-funding-schemes/therapeutic-catalyst
**Last verified:** 5 July 2026

## Eligibility & scope

Supports exploratory drug discovery to validate and de-risk targets for novel single-agent anti-cancer therapeutics. Open to academic researchers worldwide with their own lab or independent research. Projects run collaboratively with Cancer Research Horizons' Therapeutic Innovation team. Not suitable for basic biological research, combination studies, or drug repurposing.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/cancer-research-uk-therapeutic-catalyst-2026-09) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.